Explore 3 Stock Ideas & Industry Insights Download Free Report

IMAC Holdings Inc

Healthcare US BACK

0.04USD
-0.02(33.33%)

Last update at 2026-06-03T17:22:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.030.21
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap0.23M
  • Volume10
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-7.62234M
  • Revenue TTM0.02M
  • Revenue Per Share TTM0.007
  • Gross Profit TTM -0.41784M
  • Diluted EPS TTM-2.98

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -6.29778M -6.47536M -18.31281M -10.54225M -5.54244M
Minority interest - - - - 0.54M
Net income -9.04583M -9.41859M -26.74461M -11.10368M -5.56681M
Selling general administrative 2.82M 1.46M 21.80M 19.73M 15.44M
Selling and marketing expenses - 0.00773M 1.10M 1.32M 0.93M
Gross profit -0.23320M 3.85M 14.68M 12.76M 11.21M
Reconciled depreciation 0.14M 0.65M 1.63M 1.65M 1.72M
Ebit -5.61980M -6.35039M -9.84849M -9.94889M -6.47251M
Ebitda -5.48062M -5.94679M -8.24020M -8.23949M -4.74397M
Depreciation and amortization 0.14M 0.40M 1.61M 1.71M 1.73M
Non operating income net other - - - - -
Operating income -5.62327M -6.37551M -9.84849M -9.94889M -6.47251M
Other operating expenses 5.39M 6.38M 26.03M 24.33M 19.31M
Interest expense 0.68M 0.10M 0.01M 0.50M 0.56M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00347M 0.03M 0.01M 0.00288M 0.00607M
Net interest income -0.67451M -0.06551M -0.00361M -0.50122M -0.55699M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 1.71M 8.43M 0.56M 0.02M
Total revenue 0.07M 5.20M 16.19M 14.39M 12.84M
Total operating expenses 5.08M 5.03M 24.53M 22.71M 17.68M
Cost of revenue 0.31M 1.35M 1.51M 1.63M 1.62M
Total other income expense net -0.67451M -0.09985M -8.46432M -0.59335M 0.93M
Discontinued operations - - - - -
Net income from continuing ops -6.29778M -14.93339M -18.31281M -10.54225M -5.54244M
Net income applicable to common shares - - - -10.54225M -5.54244M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 1.59M 1.14M 11.08M 27.23M 19.75M
Intangible assets - - 1.37M 5.80M 6.61M
Earning assets - - - - -
Other current assets 0.15M 0.19M 0.37M 0.55M 0.31M
Total liab 7.98M 1.90M 6.43M 9.28M 11.93M
Total stockholder equity -6.39398M -0.75265M 4.65M 17.95M 10.43M
Deferred long term liab - - - 0.24M 0.24M
Other current liab 5.27M 1.31M 2.03M 0.34M 0.34M
Common stock 0.00117M 0.00115M 0.03M 0.03M 0.01M
Capital stock 0.00122M 0.00115M 0.03M 0.03M 0.01M
Retained earnings -64.98415M -55.93832M -46.51974M -28.20693M -15.04578M
Other liab - - - 0.19M 0.47M
Good will - 0.00000M 0.00000M 4.66M 2.04M
Other assets - -0.76200M - 0.67M 0.99M
Cash 0.50M 0.22M 0.76M 7.12M 2.62M
Cash and equivalents - - - - -
Total current liabilities 7.98M 1.90M 3.71M 4.93M 5.95M
Current deferred revenue - - 0.24M 0.32M 0.30M
Net debt -0.50419M -0.22151M 3.39M -1.21441M 6.51M
Short term debt - - 1.44M 1.75M 3.62M
Short long term debt - - 0.05M 0.25M 2.53M
Short long term debt total - - 4.16M 5.90M 9.14M
Other stockholder equity 58.59M 55.19M 51.14M 46.13M 25.47M
Property plant equipment - - - 7.27M 5.59M
Total current assets 0.68M 1.14M 4.21M 9.07M 4.76M
Long term investments - - - - -
Net tangible assets - - - 7.74M -0.59534M
Short term investments - - - - -
Net receivables 0.03M 0.73M 2.88M 1.21M 1.51M
Long term debt - - 0.05M 0.10M 1.96M
Inventory - - 0.20M 0.19M 0.31M
Accounts payable 2.71M 0.58M - 2.52M 1.69M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.00115M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 0.30M 0.43M 0.74M
Deferred long term asset charges - - - - -
Non current assets total 0.90M 0.76M 6.87M 18.16M 14.99M
Capital lease obligations - - 4.05M 5.55M 4.65M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.37500M -1.91404M -0.25998M -2.45750M -0.56974M
Change to liabilities - - - 0.31M -1.15705M
Total cashflows from investing activities - - - -2.45750M -0.56974M
Net borrowings 1.60M -0.03790M - -4.46184M 3.79M
Total cash from financing activities 3.82M 4.02M 4.20M 14.54M 8.81M
Change to operating activities - - - -0.28527M 0.08M
Net income -9.04583M -9.41859M -18.31281M -10.54225M -5.54244M
Change in cash 0.28M -0.54170M -6.35577M 4.50M 2.25M
Begin period cash flow 0.22M 0.76M 7.12M 2.62M 0.37M
End period cash flow 0.50M 0.22M 0.76M 7.12M 2.62M
Total cash from operating activities -0.41404M -2.79015M -10.29447M -7.59096M -5.99339M
Issuance of capital stock 2.22M 4.43M 4.47M 19.01M 5.18M
Depreciation 0.14M 0.40M 1.63M 1.65M 1.72M
Other cashflows from investing activities -0.37500M -1.77530M - - -
Dividends paid 1.25M 130.00M - - -
Change to inventory - - - -0.09663M 0.27M
Change to account receivables -0.02803M 1.45M -1.67191M 0.30M -0.23452M
Sale purchase of stock - - - - -
Other cashflows from financing activities 7.29M 4.04M -0.25998M -2.45750M 5.23M
Change to netincome - - - 0.66M -1.09501M
Capital expenditures 0.00000M 0.00000M 0.33M 0.76M 0.37M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 5.07M 0.81M -2.48458M 0.33M -1.31554M
Stock based compensation 0.04M 0.08M 0.44M 0.57M 0.39M
Other non cash items 8.46M 5.33M 8.43M 0.26M 0.24M
Free cash flow -0.41404M -2.79015M -10.62585M -8.35441M -6.36312M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BACK
IMAC Holdings Inc
-0.02 33.33% 0.04 - - 10.16 0.55 175.77 -0.5982
HCA
HCA Healthcare, Inc.
-4.12 1.12% 363.23 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
-0.18 1.69% 10.50 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
0.08 1.48% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

IMAC Holdings Inc

3401 Mallory Lane, Franklin, TN, United States, 37067

Key Executives

Name Title Year Born
Mr. Jeffrey S. Ervin M.B.A. Chairman & CEO 1978
Dr. Matthew C. Wallis Pres & Exec. Director 1974
Ms. Sheri F. Gardzina CPA, CPA CFO & Corp. Sec. 1969
Dr. Ben Lerner Chief Operating Officer 1967
Mr. Frank DeVito III Director of Sales NA
Ms. Norleidy Hernandez HR Director NA
Mr. Sandy Miller Chief of Staff NA
Dr. Matthew C. Wallis President & Director 1974
Ms. Sheri F. Gardzina CPA, CPA CFO & Corporate Secretary 1969
Ms. Sheri F. Gardzina CPA CFO & Corporate Secretary 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions